ALBEMARLE CORP (ALB): debt financing — Albemarle upsizes commercial paper program to $1.5B from $750M

ALBEMARLE CORP

Maximum aggregate face amount increased to $1.5 billion, double the prior $750 million limit.
Notes may have maturities up to 397 days; sold at discount or at par with variable rates.
No notes outstanding as of May 17, 2023; proceeds to be used for general corporate purposes.
Company's revolving credit facility backs the program; five dealers appointed.

item 2.03

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

ALBEMARLE CORP incurred debt of $1.5 billion maturing 397 days from the date of issuance.

Principal: $1.5 billion
Maturity: 397 days from the date of issuance
Event: incurrence

Exact text from the filing

On May 17, 2023, Albemarle Corporation (the “Company”) entered into definitive documentation to increase the size of its existing commercial paper program that was initiated on May 29, 2013 (the “CP Program”), under which the Company may issue short-term, unsecured commercial paper notes (the “Notes”) pursuant to an exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The maximum aggregate face amount of Notes outstanding at any time is $1.5 billion (up from $750 million prior to the increase). The Notes will be sold under customary market terms in the U.S. commercial paper market at a discount from par, or alternatively, at par and bear interest at rates that will vary based upon market conditions at the time of issuance . The maturities of the Notes may vary, but may not exceed 397 days from the date of issuance.

View on SEC.gov

Browse all debt financings →

ALBEMARLE CORP filing history →

Source: SEC EDGAR

accession 0000915913-23-000129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.